Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II)
OBJECTIVES: COVID-19 may show no peculiar signs and symptoms that may differentiate it from other infective or non-infective etiologies; thus, early recognition and prompt management are crucial to improve survival. The aim of this study was to describe clinical, laboratory, and radiological characteristics and outcomes of hospitalized COVID-19 patients compared to those with other infective or non-infective etiologies.
METHODS: We performed a prospective study from March 2020 to February 2021. All patients hospitalized for suspected or confirmed COVID-19 were prospectively recruited. All patients were evaluated according to a predefined protocol for diagnosis of suspected SARS-CoV-2 infection. The primary endpoint was evaluation of clinical, laboratory, and radiological characteristics associated or not with COVID-19 etiology at time of hospitalization in an emergency department.
RESULTS: A total of 1036 patients were included in the study: 717 (69%) patients with confirmed COVID-19 and 319 (31%) without COVID-19, hospitalized for other causes. The main causes of hospitalization among non-COVID-19 patients were acute heart failure (44%) and bacterial pneumonia (45.8%). Overall, 30-day mortality was 9% among the COVID-19 group and 35% in the non-COVID-19 group. Multivariate analysis showed variables (fever > 3 days, dry cough, acute dyspnea, lymphocytes < 1000 × 103/µL, and ferritin > 250 ng/mL) independently associated with COVID-19 etiology. A decision tree was elaborated to early detect COVID-19 patients in the emergency department. Finally, Kaplan-Meier curves on 30-day survival in COVID-19 patients during the first wave (March-May 2020, n = 289 patients) and the second wave (October-February 2021, n = 428 patients) showed differences between the two study periods (p = 0.021).
CONCLUSIONS: Patients with confirmed diagnosis of COVID-19 may show peculiar characteristics at time of hospitalization that could help physicians to distinguish from other infective or non-infective etiologies. Finally, a different 30-day mortality rate was observed during different periods of the pandemic.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Diagnostics (Basel, Switzerland) - 11(2021), 8 vom: 29. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Russo, Alessandro [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute respiratory failure |
---|
Anmerkungen: |
Date Revised 30.08.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/diagnostics11081368 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329842110 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329842110 | ||
003 | DE-627 | ||
005 | 20231225210009.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/diagnostics11081368 |2 doi | |
028 | 5 | 2 | |a pubmed24n1099.xml |
035 | |a (DE-627)NLM329842110 | ||
035 | |a (NLM)34441304 | ||
035 | |a (PII)1368 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Russo, Alessandro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II) |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.08.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a OBJECTIVES: COVID-19 may show no peculiar signs and symptoms that may differentiate it from other infective or non-infective etiologies; thus, early recognition and prompt management are crucial to improve survival. The aim of this study was to describe clinical, laboratory, and radiological characteristics and outcomes of hospitalized COVID-19 patients compared to those with other infective or non-infective etiologies | ||
520 | |a METHODS: We performed a prospective study from March 2020 to February 2021. All patients hospitalized for suspected or confirmed COVID-19 were prospectively recruited. All patients were evaluated according to a predefined protocol for diagnosis of suspected SARS-CoV-2 infection. The primary endpoint was evaluation of clinical, laboratory, and radiological characteristics associated or not with COVID-19 etiology at time of hospitalization in an emergency department | ||
520 | |a RESULTS: A total of 1036 patients were included in the study: 717 (69%) patients with confirmed COVID-19 and 319 (31%) without COVID-19, hospitalized for other causes. The main causes of hospitalization among non-COVID-19 patients were acute heart failure (44%) and bacterial pneumonia (45.8%). Overall, 30-day mortality was 9% among the COVID-19 group and 35% in the non-COVID-19 group. Multivariate analysis showed variables (fever > 3 days, dry cough, acute dyspnea, lymphocytes < 1000 × 103/µL, and ferritin > 250 ng/mL) independently associated with COVID-19 etiology. A decision tree was elaborated to early detect COVID-19 patients in the emergency department. Finally, Kaplan-Meier curves on 30-day survival in COVID-19 patients during the first wave (March-May 2020, n = 289 patients) and the second wave (October-February 2021, n = 428 patients) showed differences between the two study periods (p = 0.021) | ||
520 | |a CONCLUSIONS: Patients with confirmed diagnosis of COVID-19 may show peculiar characteristics at time of hospitalization that could help physicians to distinguish from other infective or non-infective etiologies. Finally, a different 30-day mortality rate was observed during different periods of the pandemic | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a acute respiratory failure | |
650 | 4 | |a decision tree | |
650 | 4 | |a fever | |
650 | 4 | |a mortality | |
700 | 1 | |a Gentilini Cacciola, Elio |e verfasserin |4 aut | |
700 | 1 | |a Borrazzo, Cristian |e verfasserin |4 aut | |
700 | 1 | |a Filippi, Valeria |e verfasserin |4 aut | |
700 | 1 | |a Bucci, Tommaso |e verfasserin |4 aut | |
700 | 1 | |a Vullo, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Celani, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Binetti, Erica |e verfasserin |4 aut | |
700 | 1 | |a Battistini, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Ceccarelli, Giancarlo |e verfasserin |4 aut | |
700 | 1 | |a Alessandroni, Maria |e verfasserin |4 aut | |
700 | 1 | |a Galardo, Gioacchino |e verfasserin |4 aut | |
700 | 1 | |a Mastroianni, Claudio Maria |e verfasserin |4 aut | |
700 | 1 | |a d'Ettorre, Gabriella |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostics (Basel, Switzerland) |d 2011 |g 11(2021), 8 vom: 29. Juli |w (DE-627)NLM250111136 |x 2075-4418 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:8 |g day:29 |g month:07 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/diagnostics11081368 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 8 |b 29 |c 07 |